*The following content is generated by AI and is for reference only.
<h3>Overview</h3>
<p><strong>Indisetron</strong> is a selective 5-HT3 receptor antagonist primarily developed for the management of chemotherapy-induced nausea and vomiting (CINV). Synthesized via specific heterocyclic coupling, its molecular formula is C24H29N3O2 with CAS No. 156087-56-4.</p>
<h3>Application</h3>
<ul>
<li>Oncology: Prophylaxis of acute and delayed emesis in high-dose cisplatin regimens.</li>
<li>Gastroenterology: Adjunct therapy for severe postoperative nausea.</li>
<li>Radiation Therapy: Mitigation of radiation sickness symptoms.</li>
</ul>
<h3>Precautions</h3>
<p>Contraindicated in patients with known hypersensitivity to indoles. Strictly store below 25°C in a dry, dark environment to prevent hydrolysis. Monitor QT interval prolongation risks during concurrent use with other antiemetics.</p>